Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
7.25
+0.37 (5.38%)
Aug 25, 2026, 4:00 PM EDT - Market closed
Aardvark Therapeutics Employees
Aardvark Therapeutics had 28 employees as of June 30, 2026. The number of employees decreased by 3 or -9.68% compared to the same quarter last year.
Employees
28
Change
-3
Growth
-9.68%
Revenue / Employee
n/a
Profits / Employee
-$2,496,036
Market Cap
158.67M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 28 | -3 | -9.68% | 28 | 0 |
| Mar 31, 2026 | 40 | 14 | 53.85% | 40 | 0 |
| Dec 31, 2025 | 40 | 18 | 81.82% | 40 | 0 |
| Sep 30, 2025 | 33 | 15 | 83.33% | 33 | 0 |
| Jun 30, 2025 | 31 | 17 | 121.43% | 31 | 0 |
| Mar 31, 2025 | 26 | 12 | 85.71% | 26 | 0 |
| Dec 31, 2024 | 22 | - | - | 22 | 0 |
| Sep 30, 2024 | 18 | - | - | 17 | 1 |
| Jun 30, 2024 | 14 | - | - | 12 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| LENZ Therapeutics | 152 |
| Tenaya Therapeutics | 70 |
| Connect Biopharma Holdings | 64 |
| Milestone Pharmaceuticals | 38 |
| Spruce Biosciences | 22 |
| Unicycive Therapeutics | 22 |
| Outlook Therapeutics | 17 |
| Equillium | 15 |
AARD News
- 7 days ago - AARDVARK THERAPEUTICS, INC. (AARD) INVESTOR ALERT Investors With Large Losses in Aardvark Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - Newsfile Corp
- 8 days ago - Aardvark Therapeutics reports Q2 EPS (66c), consensus (88c) - TheFly
- 11 days ago - Aardvark Therapeutics Transcript: AGM 2026 - Transcripts
- 14 days ago - Aardvark Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 14 days ago - Aardvark Therapeutics Earnings release: Q2 2026 - Filings
- 14 days ago - Aardvark Therapeutics Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Aardvark Therapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Aardvark Therapeutics Proxy statement: Proxy filing - Filings